Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bio-Rad Laboratories Inc
BIOCurrent price
256.65 USD
-1.31 USD (-0.51%)
Last closed
256.68 USD
Company
www.bio-rad.com
ISIN
US0905722072
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Capitalization
9 571 665 920 USD
Yield for 12 month
-24.76 %
1Y
3Y
5Y
10Y
15Y
BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
404.33 USDP/E ratio
–Dividend Yield
–Current Year
+2 671 262 000 USD
Last Year
+2 802 249 000 USD
Current Quarter
+649 729 000 USD
Last Quarter
+638 476 000 USD
Current Year
+1 431 346 000 USD
Last Year
+1 567 330 000 USD
Current Quarter
+355 903 000 USD
Last Quarter
+355 719 000 USD
Key Figures BIO
1 year
3 years
5 years
10 years
EBITDA
483 487 008 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
1.86 %
PEG Ratio
1.19
Return On Equity TTM
-9.79 %
Wall Street Target Price
404.33 USD
Revenue TTM
2 580 208 896 USD
Book Value
267.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.80 %
Dividend Yield
–
Gross Profit TTM
1 568 430 000 USD
Earnings per share
-28.64 USD
Diluted Eps TTM
-28.64 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
541.20 %
Profit Margin
-30.18 %
Dividend Analytics BIO
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History BIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
08.03.2002
Stock Valuation BIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
29.59
Enterprise Value Revenue
3.56
Price Sales TTM
3.71
Enterprise Value EBITDA
-13.07
Price Book MRQ
1.26
Financials BIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BIO
For 52 weeks
262.12 USD
387.99 USD
50 Day MA
341.44 USD
Shares Short Prior Month
651 703
200 Day MA
317.62 USD
Short Ratio
2.31
Shares Short
488 574
Short Percent
2.82 %
BeatStart